The analyses were conducted on the above cohorts: (1) SGLT2i and (2) GLP-1 RA with each analysis propensity score matched (PSM) for age, sex, BMI, presence of heart failure (ICD-10-CM-I50), hypertension (ICD-10-CM-I10), ischaemic heart disease (IHD) (ICD-10-CM-I2025), chronic kidney disease (CKD) (ICD-10-CM-N18) and HbA 1c value so as to balance the analysis (1:1 matching) being undertaken
It is a marketing name for compounded lipotropic injections, typically combining substances such as methionine, inositol and choline, sometimes with B vitamins or L-carnitine
Toujeo specifically enters the picture when a patient needs basal insulin and either has already tried and failed GLP-1 therapy, has a contraindication to GLP-1 drugs, has Type 1 diabetes, or has very advanced Type 2 diabetes with negligible beta cell function
How tirzepatide differs Tirzepatide takes the concept further by activating both GLP-1 and GIP receptors simultaneously
Its dual incretin and glucagon activity may help improve sensitivity to insulin and glucose regulation
(Bethesda) 31 , 283293 (2016)